The Goldman Consensus statement on depression in multiple sclerosis

被引:220
作者
Arnett, P [1 ]
Ben-Zacharia, A [1 ]
Benedict, R [1 ]
Bobholz, J [1 ]
Caruso, L [1 ]
Chelune, G [1 ]
Cox, D [1 ]
Cutter, G [1 ]
DiLorenzo, T [1 ]
DeLuca, J [1 ]
Epstein, J [1 ]
Feinstein, A [1 ]
Ferrando, SJ [1 ]
Fischer, J [1 ]
Foley, F [1 ]
Granger, C [1 ]
Halper, J [1 ]
Holland, N [1 ]
Kocsis, J [1 ]
Kalb, R [1 ]
LaRocca, N [1 ]
Lublin, F [1 ]
Miller, A [1 ]
Miller, D [1 ]
Minden, S [1 ]
Mohr, DC [1 ]
Morgante, L [1 ]
Namey, M [1 ]
Patten, SB [1 ]
Rao, SM [1 ]
Ricker, J [1 ]
Rosenthal, B [1 ]
Schiffer, R [1 ]
Schulties, M [1 ]
Schwid, S [1 ]
Wishart, H [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79430 USA
关键词
affective disorders; cognition; depression; multiple sclerosis; neuropsychiatry;
D O I
10.1191/1352458505ms1162oa
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background In January 2002 the New York City Chapter of the National Multiple Sclerosis Society convened a panel of experts to review the issue of depressive affective disorders associated with multiple sclerosis (MS). This Consensus Conference was supported by a grant from the Goldman family of New York City. Results. The panel reviewed summaries of current epidemiologic, neurobiologic, and therapeutic studies having to do with depressive disorders among MS patient populations. Depressive disorders occur at high rates among patients with MS, and there is reason to believe that the immunopathology of the disease is involved in the clinical expression of affective disorders. The depressive syndromes of MS have a major negative impact on quality of life for MS sufferers, but are treatable. At the present time, most MS patients with depression do not receive adequate recognition and treatment. Conclusions. The Goldman Consensus Conference Study Group provides recommendations for improved screening, diagnosis, and clinical management for depressive affective disorders among patients suffering from MS.
引用
收藏
页码:328 / 337
页数:10
相关论文
共 79 条
[1]  
Ackerman KD, 2000, PSYCHOSOM MED, V62, P147
[2]   A replicated prospective investigation of life stress, coping, and depressive symptoms in multiple sclerosis [J].
Aikens, JE ;
Fischer, JS ;
Namey, M ;
Rudick, RA .
JOURNAL OF BEHAVIORAL MEDICINE, 1997, 20 (05) :433-445
[3]  
ANDREASEN NC, 2000, AM PSYCH ASS DIAGNOS
[4]  
ANDRESEN NC, 2000, AM PSYCH ASS DIAGNOS
[5]   Relationship between coping, cognitive dysfunction and depression in multiple sclerosis [J].
Arnett, PA ;
Higginson, CI ;
Voss, WD ;
Randolph, JJ ;
Grandey, AA .
CLINICAL NEUROPSYCHOLOGIST, 2002, 16 (03) :341-355
[6]   Depressed mood in multiple sclerosis: Relationship to capacity-demanding memory and attentional functioning [J].
Arnett, PA ;
Higginson, CI ;
Voss, WD ;
Wright, B ;
Bender, WI ;
Wurst, JM ;
Tippin, JP .
NEUROPSYCHOLOGY, 1999, 13 (03) :434-446
[7]   Brain MRI lesions and atrophy are related to depression in multiple sclerosis [J].
Bakshi, R ;
Czarnecki, D ;
Shaikh, ZA ;
Priore, RL ;
Janardhan, V ;
Kaliszly, Z ;
Kinkel, PR .
NEUROREPORT, 2000, 11 (06) :1153-1158
[8]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[9]   Minimal neuropsychological assessment of MS patients: A consensus approach [J].
Benedict, RHB ;
Fischer, JS ;
Archibald, CJ ;
Arnett, PA ;
Beatty, WW ;
Bobholz, J ;
Chelune, GJ ;
Fisk, JD ;
Langdon, DW ;
Caruso, L ;
Foley, F ;
LaRocca, NG ;
Vowels, L ;
Weinstein, A ;
DeLuca, J ;
Rao, SM ;
Munschauer, F .
CLINICAL NEUROPSYCHOLOGIST, 2002, 16 (03) :381-397
[10]   Lesion pattern in patients with multiple sclerosis and depression [J].
Berg, D ;
Supprian, T ;
Thomae, J ;
Warmuth-Metz, M ;
Horowski, A ;
Zeiler, B ;
Magnus, T ;
Rieckmann, P ;
Becker, G .
MULTIPLE SCLEROSIS JOURNAL, 2000, 6 (03) :156-162